Gushengtang Holdings Limited

F2P · F · Healthcare / Medical Care Facilities

3.34EUR+0.02 (+0.60%)

Price History

Full chart

Market Stats

Previous Close3.32

Open3.32

Day Range3.32 – 3.34

52-Week Range1.92 – 3.35

Volume0

Market Cap617.36M

P/E (TTM)14.60

Forward P/E10.43

EPS0.20

Dividend Yield8.86%

Beta0.58

50-Day Avg3.01

200-Day Avg3.05

About

Gushengtang Holdings Limited, an investment holding company, provides healthcare services in the People's Republic of China and Singapore. It offers consultation, traditional massage, moxibustion, acupuncture, and other therapies. The company is also involved in the wholesale of pharmaceutical products; and provision of investment management and supply chain management services. It provides its services through offline medical institutions and online healthcare platforms. The company was formerly known as Gushengtang (Cayman) Ltd. and changed its name to Gushengtang Holdings Limited in September 2021. Gushengtang Holdings Limited was founded in 2010 and is headquartered in Guangzhou, the People's Republic of China.

Company Details

SectorHealthcare
IndustryMedical Care Facilities
CEOMr. Zhiliang Tu
Employees4.21K
HeadquartersNo. 419 Qingsha Road, Guangzhou, China, Germany
Websitehttps://www.gstzy.cn

Leadership

Mr. Zhiliang TuExecutive Chairman & CEO · b. 1979
Mr. Shaohua FuChief Financial Officer · b. 1991
Mr. Peng YuLegal Director & Joint Company Secretary · b. 1990
Ms. Wing Yi WanJoint Company Secretary

Financials

Income Statement

Currency: CNY	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	1.37B	1.62B	2.32B	3.02B	3.25B
Growth (%)	-	+18.40%	+43.01%	+30.09%	+7.50%
Cost of Revenue	751.79M	1.13B	1.62B	2.11B	2.24B
Gross Profit	620.30M	499.54M	700.00M	909.35M	1.01B
Gross Margin	45.21%	30.75%	30.13%	30.09%	31.16%
Operating Expense	660.74M	295.76M	421.10M	543.78M	551.19M
Operating Income	-40.43M	203.77M	278.90M	365.56M	461.22M
Operating Margin	-2.95%	12.54%	12.00%	12.10%	14.20%
EBITDA	-	324.22M	429.90M	531.87M	637.54M
EBITDA Margin	-	19.96%	18.50%	17.60%	19.62%
Net Income	-507.07M	180.85M	252.20M	306.78M	352.76M
Net Income Margin	-36.96%	11.13%	10.86%	10.15%	10.86%
Interest Expense	28.40M	17.61M	25.58M	17.61M	26.15M
Interest Expense % of Total Revenue	2.07%	1.08%	1.10%	0.58%	0.80%

Balance Sheet

Currency: CNY	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	2.40B	2.62B	3.38B	3.66B	3.99B
Total Liabilities	848.64M	900.25M	1.07B	1.28B	1.81B
Total Equity	1.55B	1.72B	2.30B	2.38B	2.17B
Cash	1.03B	994.33M	1.30B	1.12B	882.33M

Cash Flow

Currency: CNY	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	187.75M	281.00M	410.14M	452.37M	612.42M
Capital Expenditure	52.40M	37.51M	77.73M	90.61M	118.45M
Free Cash Flow	135.36M	243.49M	332.41M	361.77M	493.97M
Dividends Paid	-	-	89.76M	28.26M	163.47M
FCF to OCF	72.09%	86.65%	81.05%	79.97%	80.66%
Dividend Paid to FCF	-	-	27.00%	7.81%	33.09%

Key Statistics & Ratios

Market Cap617.36M

Enterprise Value683.74M

Trailing P/E14.60

Forward P/E10.43

Price / Sales0.18

Price / Book2.65

EPS0.20

Book Value1.16

Revenue (TTM)3.41B

Gross Profit (TTM)1.06B

EBITDA500.12M

Profit Margin12.38%

Operating Margin11.48%

Return on Equity19.63%

Return on Assets6.55%

Shares Outstanding211.42M

Shares Float148.10M

Beta0.58

Dividend Yield8.86%

Dividend Rate0.26

Payout Ratio60.40%

Dividends

20261×

0.08Jun 24, 2026

20252×

0.04Sep 11, 20250.05Jun 24, 2025

20241×

0.01Sep 5, 2024

20231×

0.05Oct 19, 2023